UOWF
DYN icon

University of Wisconsin Foundation’s Dyne Therapeutics DYN Stock Holding History

University of Wisconsin Foundation’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.96M Sell
313,559
-171,186
-35% -$3.18M 5.51% 9
2026
Q1 		$8.79M Buy
484,745
+67,995
+16% +$1.17M 7.8% 9
2025
Q4 		$8.15M Sell
416,750
-101,000
-20% -$1.91M 6.85% 7
2025
Q3 		$6.55M Buy
+517,750
New +$5.91M 5.55% 8

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

University of Wisconsin Foundation's DYN Position: Q2 2026 in Review

University of Wisconsin Foundation reduced its Dyne Therapeutics (DYN) stake by 35% in Q2 2026, selling an estimated $3.18M and leaving 313,559 shares worth $6.96M. The position accounts for 5.51% of the portfolio, ranked #9.

University of Wisconsin Foundation first reported a position in DYN in Q3 2025 and has held it in 4 quarters since. The position peaked at $8.79M in Q1 2026. 245 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • University of Wisconsin Foundation held 313,559 shares of Dyne Therapeutics worth $6.96M as of Q2 2026.
  • University of Wisconsin Foundation sold 171,186 Dyne Therapeutics shares in Q2 2026, an estimated $3.18M.
  • Dyne Therapeutics made up 5.51% of University of Wisconsin Foundation's portfolio in Q2 2026, its #9 holding.
  • University of Wisconsin Foundation first reported a position in Dyne Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • University of Wisconsin Foundation's Dyne Therapeutics position peaked at $8.79M in Q1 2026.
  • 245 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on University of Wisconsin Foundation's 13F filing for Q2 2026, filed 14 Aug 2026.